Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
SillaJen, Inc.
Onward Therapeutics
Actuate Therapeutics Inc.
Eisai Inc.
University of Maryland, Baltimore
University of Maryland, Baltimore
Takeda
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center